Aura Biosciences (AURA)

• Market cap: $349M
• 1 day: -0.54%
• 5 days: 0%
• 1 month: -3%
• 3 months: -17.79%
• 6 months: -7.09%
• Year to date: -33.41%
• 1 year: -39.82%
• 5 years: -62.84%
• 10 years: -62.84%
• Sector: Healthcare
• Industry: Biotechnology

About: Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Employees: 106